BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

LD-2 disclosure · 4th Quarter - Report

SAMERA S.A.

via OCAL LOBBYING GROUP

4th Quarter (Oct 1 - Dec 31) · 2023Posted Jan 23, 2024Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: SAMERA S.A.
Description: Monitoring Tuberculous infection & inoculation services.
Location: Paraguay

Registrant

Firm: OCAL LOBBYING GROUP
Location: Cedartown, Georgia, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
Obtain funding for Tuberculosis monitoring.
Lobbyistsmr NORMAN KEVIN CAROSELLA
TargetedNatl Institutes of Health (NIH)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

SAMERA S.A. — Lobbying — Receipts Report